XL-protein seeks € 12 VC funding (Ser.A) for its spin-out XL-biologics to develop a PASylated CD40L-Fab until the end of clinical phase I.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free